K

Sleep Apnea - Respiratory Care Pathophysiology (Video Notes)

Sleep Apnea Pathophysiology - Comprehensive Study Notes

Sleep-Related Breathing Disorders (Overview)

  • Sleep-related breathing disorders are characterized by abnormal breathing patterns during sleep.
  • Includes four main categories:
    • Obstructive sleep apnea syndrome (OSA)
    • Central sleep apnea syndrome (CSA)
    • Mixed sleep apnea
    • Sleep related hypoventilation/hypoxemia syndromes (SRHHS)
  • Important to recognize patterns of airflow, respiratory effort, and oxygenation during sleep for diagnosis and management.

Obstructive Sleep Apnea (OSA)

  • Definition
    • OSA is a blockage of ventilation due to upper airway obstruction.
    • There is no airflow despite chest and abdomen movement.
  • Pathophysiology
    • When the genioglossus muscle fails to oppose the collapse tendency of the airway during inspiration, the tongue moves into the oropharyngeal area and obstructs the airway.
  • Risk factors
    • Excessive weight
    • Neck size (>17 inches)
    • Anatomic narrowing of the upper airway:
    • Excessive pharyngeal tissue
    • Enlarged tonsils or adenoids
    • Deviated nasal septum
    • Laryngeal stenosis
    • Vocal cord dysfunction
    • Enlarged tongue (macroglossia)
    • Recessed jaw (micrognathia)
    • Age > 65 years
    • Family history
    • Smoking
    • Alcohol and sedatives
  • Signs and symptoms
    • Loud snoring
    • Observed breathing pauses during sleep
    • Abrupt awakenings with shortness of breath
    • Insomnia, moodiness, irritability
    • Concentration problems, memory impairment
    • Morning headaches, dry mouth or sore throat
    • Nausea, excessive daytime sleepiness (hypersomnia)
    • Intellectual and personality changes; depression
    • Nocturnal enuresis; sexual impotence; night sweats
  • Diagnosis: Apnea–hypopnea index (AHI) and related metrics
    • AHI is the number of apneas and hypopneas per hour of sleep; also reported are:
    • Respiratory disturbance index (RDI)
    • Arousal index (arousals per hour)
    • Percentage of each sleep stage
    • Frequency of SaO2, mean SaO2, and nadir SaO2
    • AASM severity thresholds:
    • Normal: AHI < 5
    • Mild: 5 \,\le\, AHI < 15
    • Moderate: 15 \,\le\, AHI < 30
    • Severe: AHI \,>\, 30
  • Diagnosis tools
    • History of snoring, sleep disturbance, daytime sleepiness
    • Examination of upper airway
    • Pulmonary function tests (PFTs) to evaluate airway obstruction
    • Blood tests for polycythemia, thyroid function, bicarbonate retention
    • Arterial blood gas (ABG) to assess resting oxygenation and acid-base status
    • Polysomnography (sleep study)
    • In-home portable monitoring
  • Sleep study and monitoring
    • Polysomnography monitors sleep stages and physiological parameters
    • Involves:
    • EEG, EOG, EMG (polysomnography)
    • Respiratory effort (chest/abdomen)
    • Oral and nasal airflow
    • Snoring
    • Pulse oximetry (SpO2)
    • ECG
    • Body position
    • Limb movements
  • Epworth Sleepiness Scale (for OSA risk assessment)
    • Scoring approach:
    • 0 = would never doze
    • 1 = slight chance of dozing
    • 2 = moderate chance of dozing
    • 3 = high chance of dozing
    • Situations include: sitting and reading, watching TV, sitting inactive in public, passenger in car, lying down to rest, sitting and talking to someone, sitting quietly after lunch, in a car stopped in traffic
    • Total score interpretation:
    • 0–10: Normal
    • 10–12: Borderline
    • 12–24: Abnormal
  • Mallampati classification (airway assessment prior to anesthesia, relevant for airway management and OSA risk)
    • Class 1: Soft palate, fauces, uvula, and pillars are easily seen.
    • Class 2: Soft palate, fauces, and portion of uvula seen.
    • Class 3: Soft palate and base of uvula seen.
    • Class 4: Only hard palate seen.

Central Sleep Apnea (CSA)

  • Definition
    • CSA is a disorder characterized by repetitive stopping or reduction of both airflow and ventilatory effort during sleep.
  • Types
    • Primary CSA: Idiopathic or unknown cause
    • Secondary CSA: Associated with other conditions
    • Cheyne–Stokes breathing (CHF)
    • Encephalitis
    • Brain stem neoplasm or infarction
    • Spinal surgery
    • Hypothyroidism
    • Drug or substance abuse
    • High altitude periodic breathing
  • CSA subcategories
    • Hyperventilation-related CSA (most common)
    • Hypoventilation-related CSA
  • Hyperventilation-related CSA
    • Includes primary CSA and Cheyne–Stokes breathing, and high-altitude periodic breathing
    • Patients develop alternating cycles of apnea or hypopneas with hyperpnea
  • Hypoventilation-related CSA
    • Usually secondary to underlying conditions such as:
    • Central nervous system (CNS) disease
    • CNS-suppressing drugs
    • Neuromuscular diseases
    • Severe disorders of pulmonary mechanics (e.g., COPD, pulmonary fibrosis)

Mixed Sleep Apnea

  • Definition
    • Mixed sleep apnea is a combination of obstructive and central sleep apnea.
  • Typical pattern
    • Usually begins as CSA, followed by the onset of OSA

Sleep-Related Hypoventilation/Hypoxemia Syndromes (SRHHS)

  • Broad range of sleep disorders within this category
  • Examples/typical conditions:
    • Obesity hypoventilation syndrome (OHS; Pickwickian syndrome)
    • COPD overlap: overlap between COPD and sleep apnea

Sleep Apnea Diagnosis (General Diagnostic Approach)

  • History
    • Snoring, sleep disturbance, daytime sleepiness
  • Examination
    • Upper airway assessment
  • Objective testing
    • Polysomnography (overnight sleep study)
    • In-home portable monitoring as an alternative in selected cases
  • Laboratory tests
    • Blood tests for polycythemia, thyroid function, bicarbonate retention
    • ABG to assess resting, wakeful oxygenation and acid-base status

Sleep Study: Setup and Measured Variables

  • Polysomnography measures multiple streams of data over time
  • Monitored variables include:
    • Sleep stages via EEG, EOG, and EMG
    • Respiratory efforts (movement of chest and abdomen)
    • Airflow through nose and mouth
    • Snoring
    • Pulse oximetry (SpO2)
    • Electrocardiogram (ECG)
    • Body position
    • Limb movements
  • Example visualization elements (as per study diagrams):
    • Sleep stages: wake, REM, non-REM (N1–N3)
    • REM periods with characteristic EEG/EOG/EMG patterns
    • Snore and respiratory events aligned with changes in SpO2
    • Typical 30-second epochs used for scoring

Pulmonary Function Tests and Flow–Volume Loops in OSA

  • PFTs
    • In sleep, restrictive patterns can be difficult to study during actual sleep
  • Flow–Volume Loop in OSA
    • Sawtooth pattern on the inspiratory/expiratory flow loop can be observed in some sleep-related breathing disorders
    • Example interpretation:
    • Flow (ml/s) vs Volume (ml) plots showing inspiratory/expiratory phases with sawtooth-like irregularities

Arterial Blood Gases (ABG) and Imaging

  • ABGs
    • Mild to moderate sleep-disordered breathing: typically near-normal ABG values
    • Severe disease: may show chronic ventilatory failure with hypoxemia; acute on chronic changes possible
  • Chest X-ray (CXR)
    • Often normal in early disease
    • May show enlarged heart due to pulmonary hypertension and polycythemia; can reflect right- or left-sided heart failure with prolonged apnea

Treatments for Obstructive Sleep Apnea (OSA)

  • Continuous Positive Airway Pressure (CPAP)
    • Most common treatment
    • Delivers a constant positive airway pressure throughout the ventilatory cycle to prevent airway collapse
  • Other treatment approaches
    • Weight reduction
    • Sleep posture optimization (elevating head/avoid supine position)
    • Oxygen therapy (supplemental oxygen as needed)
    • Surgery to correct anatomical defects:
    • Mandibular advancement surgery
    • Nasal surgery
    • Tracheostomy (in select severe cases)
    • Uvulopalatopharyngoplasty (UPPP): removal of soft palate tissue including the uvula
  • CPAP setup and mechanism (illustrative explanation)
    • Provides continuous positive airway pressure to keep upper airway open during sleep

Central Sleep Apnea: Treatment Considerations

  • For hyperventilation-related CSA, CPAP is considered the first-line therapy
  • For hypoventilation-related CSA, noninvasive ventilatory support is preferred:
    • BPAP (Bilevel Positive Airway Pressure) or VPAP (Variable Positive Airway Pressure) with a backup respiratory rate
    • Backup rate helps prevent abrupt shifts in PaO2, PaCO2, and pH

BPAP / VPAP (Bilevel/Variable Positive Airway Pressure)

  • Functionality
    • Delivers two different pressures: IPAP during inhalation and EPAP during exhalation
  • Typical pressure relationship
    • IPAP > EPAP; commonly the difference (pressure support) is ≥ 4\;\text{cmH2O}
  • Example provided
    • IPAP: +12 cmH2O
    • EPAP: +5 cmH2O
    • Pressure support (PS): PS = IPAP - EPAP = 12 - 5 = 7\;\text{cmH2O}
  • Nomenclature
    • IPAP: inspiratory positive airway pressure
    • EPAP: expiratory positive airway pressure

Key Formulas and Numerical References

  • Apnea–Hypopnea Index (AHI)
    • AHI = \frac{N{apneas} + N{hypopneas}}{T_{sleep}}\,.
  • Severity thresholds (AASM definitions)
    • Normal: AHI < 5
    • Mild: 5 \le AHI < 15
    • Moderate: 15 \le AHI < 30
    • Severe: AHI \ge 30
  • Pressure Support in BPAP/VPAP
    • PS = IPAP - EPAP
    • Example: IPAP = 12\;\text{cmH2O},\; EPAP = 5\;\text{cmH2O} \Rightarrow PS = 7\;\text{cmH2O}
  • Epworth Sleepiness Scale interpretation
    • Total score interpretations as described above (0–10 normal, 10–12 borderline, 12–24 abnormal)

Connections to Foundational Principles and Real-World Relevance

  • OSA pathophysiology links upper airway anatomy, neuromuscular control, and sleep physiology; obesity and craniofacial anatomy are major contributors.
  • CSA emphasizes ventilatory control instability, CNS conditions, and cardiovascular coupling (e.g., Cheyne–Stokes in heart failure).
  • Diagnostic tools (polysomnography, ABG, PFTs, CXR) integrate physiology with clinical presentation to guide treatment.
  • Treatment choices reflect balancing airway mechanics (airway pressure therapies) with underlying etiologies (neuro-muscular vs. central control problems).
  • Practical implications:
    • CPAP improves nocturnal oxygenation, reduces daytime sleepiness, and lowers cardiovascular risk in many patients with OSA.
    • BPAP/VPAP used when hypoventilation or central control issues predominate, with backup rates to stabilize gas exchange.
  • Ethical and practical considerations include access to sleep studies, adherence to CPAP therapy, and addressing comorbid conditions (e.g., obesity, COPD, heart failure).